Market requirements · CZ
Czechia
SUKL holds that most synthetic peptides meet the functional definition of a medicinal product, so classification follows function rather than the label applied at sale.
Buyers in this market search for: peptidy velkoobchod, peptidy velkoobchod private label.
| Tell us the compounds you need for Czechia. | Ask about Czechia |
The regime
How compounds are classified in Czechia
| Governing law | Czech law splits into three regimes: registered medicinal products under Act No. 378/2007 Coll., controlled and psychotropic substances under Act No. 167/1998 Coll., and substances that meet neither definition. |
|---|---|
| The regulator's stated position | SUKL, the State Institute for Drug Control, has stated that most synthetic peptides offered for sale will in fact be classified as medicinal products, because they meet the functional definition: capable of being used in humans to affect a physiological function. On that reading, a research or collector framing does not change the classification. |
| Why this matters beyond Czechia | The Czech position is the same reasoning Poland and Slovenia have published. Three national regulators arriving independently at function over labelling is better read as the likely default EU posture than as a local peculiarity. |
| GLP-1 class | SUKL monitors the grey market in semaglutide and tirzepatide specifically. |
| Enforcement posture | No SUKL enforcement action naming an EU-based B2B wholesaler was found in our research. That is an absence of evidence rather than evidence of absence. |
| Already supplying Czechia? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Czechia needs settled
- Assume the functional definition applies and work back from there, rather than starting from how a product is described.
- Hold the Czech authorisation your intended activity requires.
- Where a compound is a registered medicinal product, the pharmacy channel is the only lawful route.
- Take Czech counsel before establishing a route into or through the market.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| SUKL Pharmacovigilance notice referencing semaglutide | undated | sukl.gov.cz/farmakovigilance-cs/dulezite-informace-a-upozo... |
| Czech legislation Act No. 378/2007 Coll. on pharmaceuticals | 2007 | mze.gov.cz/public/portal/mze/legislativa/ostatni/zakon-200... |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Czechia brief as a PDF
The regime, the buyer obligations and all 2 sources, dated and linked, in one document you can forward.
Nearby
Central and Eastern Europe and nearby markets
Buyers supplying one of these usually supply the others. The requirements are not the same.
| Code | Market | Sources | |
|---|---|---|---|
| PL | Poland | 2 sources | GIF and GIS have issued a joint public warning on synthetic peptides offered a... |
| SK | Slovakia | 3 sources | SUKL named BPC-157, ipamorelin and melanotan directly in a July 2025 press rel... |
| HU | Hungary | 5 sources | OGYEI regulates medicines under Act XCV of 2005. A case-by-case research permi... |
| HR | Croatia | 1 sources | HALMED has published a general rule on online medicine sales. No notice naming... |
| SI | Slovenia | 2 sources | JAZMP published a dated warning on injectable peptides in April 2026 and names... |
| FR | France | 3 sources | ANSM names compounds individually in its public alerts and has issued sanitary... |
| IT | Italy | 1 sources | AIFA regulates under the Codice del farmaco and has warned on illegal GLP-1 su... |
Scope
How to use this page
A summary of the published regulatory position in Czechia as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Czechia
Do you supply into Czechia?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Czechia depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Czechia. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Czechia
Tell us the compounds and your authorisations. We confirm per compound before anything ships.